Advisory post highlighting the potential for divergence between drug-drug interaction warning severity levels assigned by Cegedim Healthcare Solutions and those included in the BNF and Stockley’s information for interactions.
Latest News
** RESOLVED ** Vision Consultation Manager Crashing on Failed Bulk Reauthorisation of Repeat Master Prescriptions
Tags: Clinical Safety,Vision 3
** RESOLVED ** Vision Consultation Manager crashing on failed bulk reauthorisation of repeat master prescriptions
** UPDATE - Warning Solution Implementation Assigned to DLM 850 ** Clinical Safety Issue – Age Related Prescribing Precautions not Showing when Prescribing to Neonates
Tags: Clinical Safety,Vision 3
Advisory post regarding issue relating to age-related prescribing precautions not displaying in Vision when prescribing to neonatal patients under 1 month of age (i.e. 0-28 days old).
Advisory notification of recent changes made to the dm+d by NHS Digital to the list of products that may be prescribed as imports and special orders.
Advisory notification of forthcoming changes planned to be made to the dm+d by the NHSBSA in September 2021.
Inappropriate Anti-coagulation of Patients with a Mechanical Heart Valve
Tags: Clinical Safety,Vision
Blog post on National Patient Safety Alert that has been issued on the risk of inappropriate anticoagulation of patients with a mechanical heart valve.
Advisory information on where a patient's previous acute for Methotrexate is copied and turned into a repeat master and dosage is entered as free text.
dm+d Changes to Pfizer/BioNTech Covid-19 Vaccine
Advisory notification of recent changes made to the dm+d by NHS Digital whereby imported and special order products have been added.
Advisory notification of recent changes made to the dm+d by NHS Digital whereby imported and special order products have been added.